“It’s a job you can’t find anywhere else.” That’s how Marius Rother, not without enthusiasm, describes his highly specialized role
What It’s Like to Work at amofor: An Interview with Marius Rother Read More »
Insights
As molecules grow in complexity, traditional drug formulation workflows are hitting their limits. Design of Experiments (DoE) show which formulations
Why Mechanistic Understanding Will Define the Next Decade of Drug Formulation Read More »
Perspectives
Imagine holding two drug formulations that look identical. Both contain the same active pharmaceutical ingredient (API), the same polymer, the
It’s Time to Bet on Thermal History in ASD Formulation Read More »
Science
Every pharmaceutical formulator knows this painful reality: your drug powder comes out of the spray dryer, but it still needs
How amofor Cuts Secondary Drying Times By 50% Using Physical Simulation Read More »
Case studies, Products, Science
Most machine learning models fail in formulation for one simple reason: The data they need doesn’t exist.You can’t generate shelf
How can formulation scientists make more thoughtful decisions without becoming thermodynamics experts? That’s the question that led to SOLCALC. SOLCALC
SOLCALC Training: Turning Complex Physical Modeling Into Actionable Insights Read More »
Solcalc
Can predictive modeling replace years of drug stability testing? This case study explores how researchers of Janssen Pharmaceuticals, TU Dortmund
We redefined ASD Shelf Life Predictions – Key Insights from a 2-Year Case Study Read More »
Case studies
Creating effective and stable drug formulations shouldn’t be guesswork. It’s deeply rooted in science. Yet, many formulators still rely on
Why Five Solubility Points Are All You Need to Design a Drug Formulation Read More »
Case studies
Spray drying is a leading technique for manufacturing amorphous solid dispersions (ASDs). At its core lies atomization: you dissolve an
Our Thermodynamic Spray Dryer Modeling – Your Digital Microscope In Spray Drying Read More »
Case studies, Science
As pharmaceutical research pushes towards previously “undruggable” targets, the challenge often boils down to one key issue: complex drugs with
